World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
40562
World Ranking
14387
National Ranking
7276

Charles L. Shapiro publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles L. Shapiro sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 323 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles L. Shapiro D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles L. Shapiro sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles L. Shapiro is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their primary field of study is Medicine, with a focused interest on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, and Orthopedics and Sports Medicine.

Their research centers on several main topics, including:

  • Advanced Breast Cancer Therapies
  • Cancer Treatment and Pharmacology
  • HER2/EGFR in Cancer Research
  • Bone health and treatments
  • Breast Cancer Treatment Studies
  • Cancer survivorship and care
  • Bone health and osteoporosis research

Charles L. Shapiro has contributed notably to various scientific publications, with frequent appearances in journals such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • UNC Libraries
  • Breast Cancer Research and Treatment
  • Cancers

Some recent papers associated with or relevant to their field are:

  • "Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,800 women from 86 randomised trials," 2023, The Lancet
  • "Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis," 2020, Breast Cancer Research and Treatment
  • "Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018," 2021, Cancer
  • "Self-reported Transportation Barriers to Health Care Among US Cancer Survivors," 2022, JAMA Oncology
  • "Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments," 2020, Cancers

Their collaborative network includes frequent coauthors such as:

  • Changchuan Jiang
  • Lei Deng
  • Stuthi Perimbeti
  • Julie Fasano
  • Daniel G. Stover

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

    Kevin S. Hughes;Lauren A. Schnaper;Donald Berry;Constance Cirrincione

  • Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

    Ellen M. Lavoie Smith;Herbert Pang;Constance Cirrincione;Stewart Fleishman

  • American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects

    Joseph R. Carver;Charles L. Shapiro;Andrea Ng;Linda Jacobs

  • Side Effects of Adjuvant Treatment of Breast Cancer

    Charles L. Shapiro;Abram Recht

  • MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1

    Tyler E. Miller;Kalpana Ghoshal;Bhuvaneswari Ramaswamy;Satavisha Roy

  • Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

    Andrew D. Seidman;Donald Berry;Constance Cirrincione;Lyndsay Harris

  • Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

    Fergus J. Couch;Steven N. Hart;Priyanka Sharma;Amanda Ewart Toland

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial

    Barbara L. Andersen;William B. Farrar;Deanna M. Golden-Kreutz;Ronald Glaser

  • Ovarian Failure After Adjuvant Chemotherapy Is Associated With Rapid Bone Loss in Women With Early-Stage Breast Cancer

    Charles L. Shapiro;Judith Manola;Meryl Leboff

  • Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial

    Janice K. Kiecolt-Glaser;Jeanette M. Bennett;Rebecca Andridge;Juan Peng

  • Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.

    C L Shapiro;P H Hardenbergh;R Gelman;D Blanks

  • The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

    SR Young;Robert T Pilarski;Talia Donenberg;Charles Shapiro

  • Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline

    Noam Yarom;Noam Yarom;Charles L Shapiro;Douglas E Peterson;Catherine H Van Poznak

  • Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

    Andrew L. Himelstein;Jared C. Foster;James L. Khatcheressian;John D. Roberts

  • Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.

    Pearlly S. Yan;Chinnambally Venkataramu;Ashraf Ibrahim;Joseph C. Liu

  • Hedgehog signaling is a novel therapeutic target in tamoxifen resistant breast cancer aberrantly activated by PI3K/AKT pathway

    Bhuvaneswari Ramaswamy;Yuanzhi Lu;Kun-yu Teng;Gerard Nuovo

  • Cardiac safety of liposomal anthracyclines

    Michael S. Ewer;Francis J. Martin;I. Craig Henderson;Charles L. Shapiro

Frequent Co-Authors

Ching-Shih Chen
Ching-Shih Chen The Ohio State University
Robert Pilarski
Robert Pilarski Ambry Genetics (United States)
William E. Carson
William E. Carson The Ohio State University
Michael R. Grever
Michael R. Grever The Ohio State University
Barbara L. Andersen
Barbara L. Andersen The Ohio State University
Kay Huebner
Kay Huebner The Ohio State University
Michael V. Knopp
Michael V. Knopp The Ohio State University Wexner Medical Center
Eric P. Winer
Eric P. Winer Yale University
Jeffrey J. Chalmers
Jeffrey J. Chalmers The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open doors for those interested in healthcare and medicine in the USA. Aspiring nurses and advanced practice providers have more flexible, accessible options than ever before.

For registered nurses seeking leadership or advanced practitioner roles, the quickest dnp program options allow students to earn a Doctor of Nursing Practice degree efficiently, often in less time than traditional routes. Those concerned about cost can look at the cheapest online dnp programs, which combine affordability with accredited coursework.

If you want to quickly enter the nursing field, a 6 month lpn program online may be an option, providing pathways to licensure in less than a year. Meanwhile, those interested in mental health can consider online pmhnp programs—an excellent way to specialize in psychiatric and mental health nursing through flexible, virtual coursework.

These online options help future medical professionals advance their careers without sacrificing flexibility or quality.

Best Scientists Citing Charles L. Shapiro

Trending Scientists

Recently Published Articles